These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 30332965

  • 1. Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells.
    Wei J, Ma L, Li C, Pierson CR, Finlay JL, Lin J.
    Curr Cancer Drug Targets; 2019; 19(7):571-582. PubMed ID: 30332965
    [Abstract] [Full Text] [Related]

  • 2. Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma.
    Lue HW, Cole B, Rao SA, Podolak J, Van Gaest A, King C, Eide CA, Wilmot B, Xue C, Spellman PT, Heiser LM, Tyner JW, Thomas GV.
    Oncotarget; 2015 Dec 29; 6(42):44675-87. PubMed ID: 26625308
    [Abstract] [Full Text] [Related]

  • 3. Abrogation of signal transducer and activator of transcription 3 reactivation after Src kinase inhibition results in synergistic antitumor effects.
    Johnson FM, Saigal B, Tran H, Donato NJ.
    Clin Cancer Res; 2007 Jul 15; 13(14):4233-44. PubMed ID: 17634553
    [Abstract] [Full Text] [Related]

  • 4. Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.
    Sen B, Saigal B, Parikh N, Gallick G, Johnson FM.
    Cancer Res; 2009 Mar 01; 69(5):1958-65. PubMed ID: 19223541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.
    Ho WS, Feldman MJ, Maric D, Amable L, Hall MD, Feldman GM, Ray-Chaudhury A, Lizak MJ, Vera JC, Robison RA, Zhuang Z, Heiss JD.
    Oncotarget; 2016 Mar 15; 7(11):12447-63. PubMed ID: 26799670
    [Abstract] [Full Text] [Related]

  • 10. New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells.
    Rossi A, Schenone S, Angelucci A, Cozzi M, Caracciolo V, Pentimalli F, Puca A, Pucci B, La Montagna R, Bologna M, Botta M, Giordano A.
    FASEB J; 2010 Aug 15; 24(8):2881-92. PubMed ID: 20354138
    [Abstract] [Full Text] [Related]

  • 11. LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells.
    Chen X, Pan L, Wei J, Zhang R, Yang X, Song J, Bai RY, Fu S, Pierson CR, Finlay JL, Li C, Lin J.
    Sci Rep; 2021 Mar 22; 11(1):6517. PubMed ID: 33753770
    [Abstract] [Full Text] [Related]

  • 12. Combined blockade of Src kinase and epidermal growth factor receptor with gemcitabine overcomes STAT3-mediated resistance of inhibition of pancreatic tumor growth.
    Nagaraj NS, Washington MK, Merchant NB.
    Clin Cancer Res; 2011 Feb 01; 17(3):483-93. PubMed ID: 21266529
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress.
    Kopetz S, Lesslie DP, Dallas NA, Park SI, Johnson M, Parikh NU, Kim MP, Abbruzzese JL, Ellis LM, Chandra J, Gallick GE.
    Cancer Res; 2009 May 01; 69(9):3842-9. PubMed ID: 19383922
    [Abstract] [Full Text] [Related]

  • 16. STAT3 inhibitor in combination with irradiation significantly inhibits cell viability, cell migration, invasion and tumorsphere growth of human medulloblastoma cells.
    Pan L, Zhang R, Ma L, Pierson CR, Finlay JL, Li C, Lin J.
    Cancer Biol Ther; 2021 Sep 02; 22(7-9):430-439. PubMed ID: 34254873
    [Abstract] [Full Text] [Related]

  • 17. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
    Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA.
    Proc Natl Acad Sci U S A; 2017 Apr 11; 114(15):3975-3980. PubMed ID: 28356514
    [Abstract] [Full Text] [Related]

  • 18. Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells.
    Pichot CS, Hartig SM, Xia L, Arvanitis C, Monisvais D, Lee FY, Frost JA, Corey SJ.
    Br J Cancer; 2009 Jul 07; 101(1):38-47. PubMed ID: 19513066
    [Abstract] [Full Text] [Related]

  • 19. Targeted inhibition of SRC kinase signaling attenuates pancreatic tumorigenesis.
    Nagaraj NS, Smith JJ, Revetta F, Washington MK, Merchant NB.
    Mol Cancer Ther; 2010 Aug 07; 9(8):2322-32. PubMed ID: 20682659
    [Abstract] [Full Text] [Related]

  • 20. Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer.
    Dosch AR, Dai X, Reyzer ML, Mehra S, Srinivasan S, Willobee BA, Kwon D, Kashikar N, Caprioli R, Merchant NB, Nagathihalli NS.
    Mol Cancer Res; 2020 Apr 07; 18(4):623-631. PubMed ID: 31949002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.